黄金城集团

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Small-Molecule Neuromedin U Receptor 2 Agonists Suppress Food Intake and Decrease Visceral Fat in Animal Models.

Pharmacol Res Perspect. 2018-10; 
SampsonCatherine M,KasperJames M,FelsingDaniel E,RavalSweta R,YeNa,WangPingyuan,PatrikeevIgor,RyttingErik,ZhouJia,AllenJohn A,HommelJonath
Products/Services Used Details Operation
… verified using HPLC analysis. 2.3 Cell culture. Human Embryonic Kidney 293 (HEK293) cells and HEK293 stably expressing the human NMUR2 receptor (C11 cells) were obtained from GenScript (cat no. M00244 Piscataway, NJ …

摘要

Obesity is a growing public health concern, with 37.5% of the adult population in need of therapeutics that are more efficacious with a better side effect profile. An innovative target in this regard is neuromedin U, a neuropeptide shown to suppress food intake and attenuate weight gain in animal models. These effects of neuromedin U on feeding behavior are thought to be related to agonism at the centrally expressed neuromedin U receptor 2 (NMUR2). As peptides present unique challenges that limit their therapeutic potential, the discovery of small-molecule NMUR2 agonists is needed to validate the targets therapeutic value, but to date, none have been evaluated in any animal model of disease. We theref... More

关键词

Neuromedin U receptor 2,calcium,cyclic AMP,feeding,high‐fat diet,obesity,small‐molecule ago